Breakthroughs in Psychedelic Chemistry: Discovering the World’s First Novel Salts and Polymorphs of Psilocybin, MDMA, LSD and Other Psychedelic Compounds
Fill out the form below and we'll send your colleague an invitation to the "Breakthroughs in Psychedelic Chemistry: Discovering the World’s First Novel Salts and Polymorphs of Psilocybin, MDMA, LSD and Other Psychedelic Compounds" event.
In this webinar we will explore novel salts and polymorphs of psychedelic substances, including Dr. Sam Clark's discovery of the first new salts and polymorphs of psilocybin, MDMA, LSD, Methylone and other compounds. The importance of salts and polymorphs for novel therapeutics will also be discussed as well as the process of discovery, identification and characterization. Finally, we will discuss the criteria involved in choosing the salts and polymorphs that are most suitable for development into pharmaceutical formulations and their therapeutic applications for patients with neuropsychiatric conditions.
Attend this webinar to discover:
- New forms of psilocybin, MDMA, LSD and more
- Why salts and polymorphs are crucial for developing innovative therapeutics in neuropsychiatric conditions
- The criteria used to select salts and polymorphs for pharmaceutical development, enhancing therapeutic applications for patients
